Prospective randomized double-blind comparison of nephrotoxicity and auditory toxicity of tobramycin and netilmicin.

AUTOR(ES)

Gatell, J M

RESUMO

Netilmicin or tobramycin was administered to 197 patients in a prospective randomized double-blind trial. Of these patients, 140 recipients of nine or more doses of netilmicin or tobramycin could be evaluated for nephrotoxicity. Fifty-five patients were able to cooperate in the administration of serial audiograms. Nephrotoxicity of similar severity developed in 7 of 73 (9.6%) recipients of tobramycin and in 7 of 67 (10.4%) recipients of netilmicin (P greater than 0.05). Mild or slight auditory toxicity developed in 5 of 28 (17.8%) recipients of tobramycin and in 2 of 27 (7.4%) recipients of netilmicin (P greater than 0.05).

Documentos Relacionados

• Effects of prophylactic antibiotics in vascular surgery. A prospective, randomized, double-blind study.
• Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity.
• Randomized, double-blind comparison of ceftazidime and moxalactam in complicated urinary tract infections.
• Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis.
• Prophylactic platelet administration during massive transfusion. A prospective, randomized, double-blind clinical study.